Shanghai Junshi Biosciences Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Junshi Biosciences has a total shareholder equity of CN¥6.3B and total debt of CN¥2.8B, which brings its debt-to-equity ratio to 43.8%. Its total assets and total liabilities are CN¥10.9B and CN¥4.6B respectively.
Key information
43.8%
Debt to equity ratio
CN¥2.75b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥3.04b |
| Equity | CN¥6.28b |
| Total liabilities | CN¥4.58b |
| Total assets | CN¥10.86b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SHJB.F's short term assets (CN¥4.6B) exceed its short term liabilities (CN¥2.3B).
Long Term Liabilities: SHJB.F's short term assets (CN¥4.6B) exceed its long term liabilities (CN¥2.3B).
Debt to Equity History and Analysis
Debt Level: SHJB.F has more cash than its total debt.
Reducing Debt: SHJB.F's debt to equity ratio has increased from 25% to 43.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SHJB.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SHJB.F has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 12.4% each year.